- Home
- HUMA vs BGIN Comparison
HUMA vs BGIN Comparison
Compare HUMA & BGIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- BGIN
- Stock Information
- Founded
- HUMA 2004
- BGIN 2019
- Country
- HUMA United States
- BGIN Singapore
- Employees
- HUMA N/A
- BGIN N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- BGIN
- Sector
- HUMA Health Care
- BGIN
- Exchange
- HUMA Nasdaq
- BGIN Nasdaq
- Market Cap
- HUMA 324.0M
- BGIN 387.8M
- IPO Year
- HUMA N/A
- BGIN 2025
- Fundamental
- Price
- HUMA $1.67
- BGIN $4.01
- Analyst Decision
- HUMA Strong Buy
- BGIN
- Analyst Count
- HUMA 7
- BGIN 0
- Target Price
- HUMA $10.00
- BGIN N/A
- AVG Volume (30 Days)
- HUMA 7.5M
- BGIN 644.1K
- Earning Date
- HUMA 11-07-2025
- BGIN 11-22-2025
- Dividend Yield
- HUMA N/A
- BGIN N/A
- EPS Growth
- HUMA N/A
- BGIN N/A
- EPS
- HUMA N/A
- BGIN 0.61
- Revenue
- HUMA $818,000.00
- BGIN $302,277,581.00
- Revenue This Year
- HUMA N/A
- BGIN N/A
- Revenue Next Year
- HUMA $1,468.13
- BGIN N/A
- P/E Ratio
- HUMA N/A
- BGIN $6.56
- Revenue Growth
- HUMA N/A
- BGIN 17.50
- 52 Week Low
- HUMA $1.15
- BGIN $3.81
- 52 Week High
- HUMA $6.77
- BGIN $6.50
- Technical
- Relative Strength Index (RSI)
- HUMA 47.73
- BGIN N/A
- Support Level
- HUMA $1.65
- BGIN N/A
- Resistance Level
- HUMA $1.78
- BGIN N/A
- Average True Range (ATR)
- HUMA 0.10
- BGIN 0.00
- MACD
- HUMA -0.01
- BGIN 0.00
- Stochastic Oscillator
- HUMA 23.73
- BGIN 0.00
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.